TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.

Tony S Mok et al.PubMed ↗Publisher ↗

No numbers read from the abstract.